Answers are grounded in this paper and cite their sources.
Calcium/calmodulin-dependent protein kinase type II, a multimeric 550-650 kilodalton enzyme composed of major alpha (50 kilodalton) and beta/beta' (60/58 kilodalton) subunits, is present in high concentrations in mammalian brain. Previous immunocytochemical studies indicated that the enzyme is enriched in cell bodies and dendrites, but did not show a clear-cut localization in nerve terminals. The present study presents evidence, using lesion-induced degenerations of pre- and postsynaptic neuronal populations in the neostriatum and substantia nigra, that calcium/calmodulin-dependent protein kinase II, as measured both by autophosphorylation of enzyme subunits and by synapsin I kinase activity, is present in high concentrations in several populations of presynaptic terminals. Lesions of the corticostriatal tract decreased the amount of enzyme by 30-40% in the neostriatum, a decrease similar to that seen in the same region of synapsin I, a general nerve terminal marker. Lesions of the striatonigral tract induced an even more pronounced decrease of the enzyme in the substantia nigra; this decrease was larger than the lesion-induced change of synapsin I seen in the same region. Our data therefore indicate that certain nerve terminal populations in the rat brain contain high levels of calcium/calmodulin-dependent protein kinase II.
No takes yet. Share an insight, caveat, or question.
Walaas et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: